메뉴 건너뛰기




Volumn 53, Issue 9, 2010, Pages 575-579

Synthesis and biodistribution studies of 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model

Author keywords

Breast cancer; DOTA; Lutetium 177; Radioimmunotherapy; Trastuzumab

Indexed keywords

DISEASES; MEDICAL IMAGING; MONOCLONAL ANTIBODIES; TUMORS;

EID: 77956906713     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1780     Document Type: Article
Times cited : (14)

References (27)
  • 3
    • 85167466952 scopus 로고    scopus 로고
    • administration-USA FDA, editor. Food and Drug administration Report, U.S. Department of Health and Human Services
    • New monoclonal antibody approved for advanced breast cancer. In: administration-USA FDA, editor. Food and Drug administration Report, U.S. Department of Health and Human Services 1998, 98-27.
    • (1998) New Monoclonal Antibody Approved for Advanced Breast Cancer , pp. 98-127
  • 18


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.